Company: SNSE
Filing Date: 2025-04-01
Form Type: PRE 14A
Source: 0000950170-25-048533
Chunk: 19

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-01
Form: PRE 14A
Chunk 19
---
 |     |   |
| James Peyer, Ph.D.         |     |                 |   |     |   |     | X            |   |     |   |     | X              |   |     |   |
| Samuel Broder, M.D. (2)    |     |                 |   |     |   |     |              |   |     |   |     | X              |   |     |   |
| Thomas Ricks               |     | X               |   |     | * |     | X            |   |     |   |     |                |   |     |   |
| Deneen Vojta, M.D. (3)     |     |                 |   |     |   |     | X            |   |     |   |     | X              |   |     | * |
| Jessie English, Ph.D. (4)  |     |                 |   |     |   |     |              |   |     |   |     | X              |   |     |   |
| Kristian Humer             |     | X               |   |     |   |     |              |   |     |   |     |                |   |     |   |
| Number of meetings in 2024 |     |                 | 4 |     |   |     |              | 3 |     |   |     |                | 0 |     |   |

* Current Committee Chair.

(1) On February 5, 2024, Dr. Broder resigned from the Board of Directors. Following Dr. Broder's resignation, on February 5, 2024 the Board of Directors appointed Mr. Ringo as Interim Chair of the Nominating and Corporate Governance Committee. On June 11, 2024 Dr. Vojta was appointed as Chair of the Nominating and Corporate Governance Committee and ceased serving on the Compensation Committee.

(2) On February 5, 2024, Dr. Broder resigned from the Board of Directors, effective immediately.

(3) On October 25, 2024, Dr. Vojta resigned from the Board of Directors, effective December 31, 2024. Following Dr. Vojta's resignation, the Board of Directors appointed Mr. Ringo as Chair of the Nominating and Corporate Governance Committee, effective January 1, 2025.

(4) On June 26, 2024, Dr